Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

DOI Full Paper Access

33

Citations

16

References

2018

Year

Bristi Basu, Matthew Krebs, Raghav Sundar, Richard H. Wilson, James Spicer, Robert H. Jones, M. Brada, Denis Talbot, Nicola Steele, Alvaro Ingles Garces,

Annals of Oncology

References

	Year	Citations

Page 1